IBB Overview
Upcoming Projects (IBB)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (IBB)
-
A second look: Discussing AI use in drug discovery and development
Ticker: IBB
Executed On: Mar 25, 2024 at 02:30 PM EDT -
Discussing AI use in drug discovery and development
Ticker: IBB
Executed On: Mar 25, 2024 at 12:00 PM EDT -
Looking at the future use of Ketamine-based products for the treatment of patients with depression and schizophrenia
Tickers: JNJ, IBB
Executed On: Nov 20, 2023 at 04:35 PM EST -
A pediatrician's view on the treatment landscape and new therapies/vaccines on the horizon for RSV
Ticker: IBB
Executed On: Apr 21, 2023 at 02:00 PM EDT -
A second look: Gaining perspective into the limitations on patient access to drugs such as Xanax and Adderall after recent opioid settlements
Ticker: IBB
Executed On: Apr 13, 2023 at 09:00 AM EDT -
Gaining perspective into the limitations on patient access to drugs such as Xanax and Adderall after recent opioid settlements
Ticker: IBB
Executed On: Apr 11, 2023 at 02:00 PM EDT -
A Third Look at Bone Marrow Aspirate Stem Cell Concentrate (BMAC)
Ticker: IBB
Executed On: Jan 06, 2023 at 09:00 AM EST -
A second discussion on the available interchangeable biosimilar insulin products
Ticker: IBB
Executed On: Jan 05, 2023 at 04:30 PM EST -
A discussion on the available interchangeable biosimilar insulin products
Ticker: IBB
Executed On: Jan 05, 2023 at 01:30 PM EST -
Understanding the development of a potential flu vaccine utilizing mRNA technology to protect against many subtypes of the Influenza Virus
Ticker: IBB
Executed On: Dec 20, 2022 at 01:00 PM EST -
A Second Look at Bone Marrow Aspirate Stem Cell Concentrate (BMAC)
Ticker: IBB
Executed On: Dec 15, 2022 at 04:15 PM EST -
A Fourth View: Understanding the progression of antibiotic resistance, the development of new antibiotics, and the potential of the PASTEUR Act which has been introduced to Congress.
Ticker: IBB
Executed On: Dec 13, 2022 at 02:00 PM EST -
A Third Take: Discussing the Pharmacy view on the recent shortage of amoxicillin
Ticker: IBB
Executed On: Dec 09, 2022 at 08:00 AM EST -
A discussion on the standard of care and unmet needs in the acne treatment landscape, and the generic vs branded drugs available for acne treatment.
Ticker: IBB
Executed On: Dec 07, 2022 at 10:00 AM EST -
A Third View: Understanding the progression of antibiotic resistance, the development of new antibiotics, and the potential of the PASTEUR Act which has been introduced to Congress.
Ticker: IBB
Executed On: Dec 06, 2022 at 04:30 PM EST -
A Second Take: Discussing the Pharmacy view on the recent shortage of amoxicillin
Ticker: IBB
Executed On: Dec 01, 2022 at 05:30 PM EST -
A Second View: Understanding the progression of antibiotic resistance, the development of new antibiotics, and the potential of the PASTEUR Act which has been introduced to Congress.
Ticker: IBB
Executed On: Dec 01, 2022 at 02:30 PM EST -
Discussing the biggest challenges for allogeneic T cell programs and what advantages these may have over autologous T cells
Ticker: IBB
Executed On: Dec 01, 2022 at 08:00 AM EST -
Understanding the progression of antibiotic resistance, the development of new antibiotics, and the potential of the PASTEUR Act which has been introduced to Congress.
Ticker: IBB
Executed On: Nov 23, 2022 at 04:00 PM EST -
A First Look at Bone Marrow Aspirate Stem Cell Concentrate (BMAC)
Ticker: IBB
Executed On: Nov 21, 2022 at 05:00 PM EST -
Discussing the Pharmacy view on the recent shortage of amoxicillin
Ticker: IBB
Executed On: Nov 17, 2022 at 06:00 PM EST -
A fourth view: discussing the potential of low dose naltrexone for treating Post-COVID fatigue syndrome
Ticker: IBB
Executed On: Oct 27, 2022 at 05:00 PM EDT -
A third view: discussing the potential of low dose naltrexone for treating Post-COVID fatigue syndrome
Ticker: IBB
Executed On: Oct 27, 2022 at 12:00 PM EDT -
A second view: discussing the potential of low dose naltrexone for treating Post-COVID fatigue syndrome
Ticker: IBB
Executed On: Oct 26, 2022 at 02:00 PM EDT -
Discussing the potential of low dose naltrexone for treating Post-COVID fatigue syndrome
Ticker: IBB
Executed On: Oct 25, 2022 at 04:15 PM EDT -
Key Takeaways from HFSA: A conversation on new and emerging clinical options and therapies in the heart failure space
Ticker: IBB
Executed On: Oct 25, 2022 at 02:00 PM EDT -
A look at the potential of psilocybin in improving the percentage of heavy drinking days in patients with Alcohol Use Disorder(AUD) based on Phase 2 data
Ticker: IBB
Executed On: Sep 16, 2022 at 02:00 PM EDT -
A Second Look: Discussing next generation cell therapy in the oncology space with a focus on gamma delta (γδ) T Cells and their therapeutic indications
Ticker: IBB
Executed On: Jan 20, 2022 at 09:00 AM EST -
Discussing next generation cell therapy in the oncology space with a focus on gamma delta (γδ) T Cells and their therapeutic indications
Ticker: IBB
Executed On: Jan 05, 2022 at 10:00 AM EST
Upcoming & Overdue Catalysts (IBB)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (IBB)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
